Tuesday, March 18, 2025 | 06:15 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Granules India arm gets USFDA nod for generic version of Roche antiviral

Valganciclovir hydrochloride solution is an antiviral medication used to treat cytomegalovirus infections.

Pharma, medicine, drugs, Pharmaceuticals

Press Trust of India New Delhi

Drug firm Granules India Ltd on Wednesday said its foreign arm has received approval from the US health regulator for Valganciclovir hydrochloride oral solution, an antiviral medication.

"The US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc, a-wholly owned foreign subsidiary of Granules India Ltd for Valganciclovir hydrochloride for oral solution, 50 mg/ml," the company said in a regulatory filing.

It is bioequivalent to the reference listed drug product (RLD) -- Valcyte for oral solution, 50 mg/m, of Roche Palo Alto LLC, the filing said.

Valganciclovir hydrochloride solution is an antiviral medication used to treat cytomegalovirus infections.

 

Shares of Granules India were trading at Rs 153 a piece on BSE, up 4.83 per cent from the previous close.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 05 2020 | 10:32 AM IST

Explore News